Fundamental dimension Equity attribute | APCAPeer $11.45▼-0.04% Cap $178.8MP/E 67.4x QuantScore35/100 | ACROLeader $10.45▲+0.00% Cap $173.7MP/E 1771.2x QuantScore54/100 | BIOSPeer $10.80▼-0.05% Cap $209.1MP/E 54.0x QuantScore52/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
76/100 |
73/100 |
69/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 33/100 | 38/100 |
Health Piotroski, Altman Z, leverage & liquidity | 54/100 | 59/100 | 54/100 |
Growth Revenue / earnings growth & margins | 9/100 | 50/100 | 50/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 67.4x | 1771.2x | 54.0x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -38.8x | 178.9x | 182691.6x |
Price / Sales | — | — | — |
Price / Free Cash Flow | -311.8x | -66.4x | -302.4x |
PEG ratio | -2.22 | 0.00 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 3 / 9 | 2 / 9 |
Altman Z-Score | 7.19 (Safe) | 5.03 (Safe) | 7.26 (Safe) |
Total debt / equity | 0.03 | 0.01 | 0.02 |
Quick ratio | 0.0x | 0.1x | 1.0x |
Interest coverage | — | 94.4x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | — |
Net income growth YoY | +1.3% | +115.4% | +3375823.3% |
Gross margin (TTM) | 0.0% | 0.0% | 0.0% |
Operating margin (FY) | — | — | — |
FCF margin (FY) | — | — | — |
5. Trailing price performancePrice change over period |
1M return | 0.0% | +0.0% | -0.0% |
3M return | +1.0% | +1.5% | +0.8% |
6M return | +2.5% | +3.3% | +2.9% |
Year to date | +2.9% | 0.0% | +5.1% |
1Y return | +6.0% | +4.4% | +6.6% |
3Y return | +16.1% | +7.5% | +10.2% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | — — | — — | — — |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |